A detailed history of Ifm Investors Pty LTD transactions in Merck & Co., Inc. stock. As of the latest transaction made, Ifm Investors Pty LTD holds 531,758 shares of MRK stock, worth $52.1 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares
531,758
Previous 528,172 0.68%
Holding current value
$52.1 Million
Previous $65.4 Million 7.65%
% of portfolio
0.59%
Previous 0.67%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$111.15 - $128.97 $398,583 - $462,486
3,586 Added 0.68%
531,758 $60.4 Million
Q2 2024

Aug 14, 2024

BUY
$123.8 - $132.96 $789,720 - $848,151
6,379 Added 1.22%
528,172 $65.4 Million
Q1 2024

Apr 22, 2024

SELL
$113.24 - $131.95 $235,086 - $273,928
-2,076 Reduced 0.4%
521,793 $68.9 Million
Q4 2023

Jan 12, 2024

BUY
$100.18 - $109.02 $517,830 - $563,524
5,169 Added 1.0%
523,869 $57.1 Million
Q3 2023

Oct 26, 2023

BUY
$102.95 - $114.33 $1.39 Million - $1.54 Million
13,511 Added 2.67%
518,700 $53.4 Million
Q2 2023

Jul 27, 2023

BUY
$108.61 - $118.38 $2.67 Million - $2.92 Million
24,628 Added 5.12%
505,189 $58.3 Million
Q1 2023

May 11, 2023

BUY
$102.94 - $114.86 $1.47 Million - $1.64 Million
14,294 Added 3.07%
480,561 $51.1 Million
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $2.51 Million - $3.22 Million
28,701 Added 6.56%
466,267 $51.7 Million
Q3 2022

Oct 12, 2022

BUY
$84.53 - $94.96 $561,194 - $630,439
6,639 Added 1.54%
437,566 $37.7 Million
Q2 2022

Jul 15, 2022

BUY
$83.49 - $94.64 $2.43 Million - $2.76 Million
29,136 Added 7.25%
430,927 $39.3 Million
Q1 2022

Apr 13, 2022

BUY
$73.51 - $82.4 $4.94 Million - $5.54 Million
67,249 Added 20.1%
401,791 $33 Million
Q4 2021

Jan 18, 2022

SELL
$72.28 - $90.54 $301,335 - $377,461
-4,169 Reduced 1.23%
334,542 $25.6 Million
Q3 2021

Oct 13, 2021

BUY
$71.68 - $78.83 $25,733 - $28,299
359 Added 0.11%
338,711 $25.4 Million
Q2 2021

Jul 16, 2021

BUY
$70.31 - $77.77 $4.21 Million - $4.66 Million
59,923 Added 21.52%
338,352 $26.3 Million
Q1 2021

May 05, 2021

BUY
$68.86 - $81.11 $2.36 Million - $2.78 Million
34,327 Added 14.06%
278,429 $21.5 Million
Q4 2020

Jan 13, 2021

BUY
$71.77 - $79.65 $2.51 Million - $2.78 Million
34,953 Added 16.71%
244,102 $20 Million
Q3 2020

Oct 16, 2020

BUY
$73.18 - $82.95 $1.61 Million - $1.83 Million
22,046 Added 11.78%
209,149 $17.3 Million
Q2 2020

Jul 13, 2020

SELL
$70.42 - $80.13 $5.24 Million - $5.96 Million
-74,347 Reduced 28.44%
187,103 $14.5 Million
Q1 2020

Apr 09, 2020

SELL
$63.36 - $87.82 $613,198 - $849,921
-9,678 Reduced 3.57%
261,450 $20.1 Million
Q4 2019

Jan 13, 2020

SELL
$77.58 - $87.54 $555,705 - $627,049
-7,163 Reduced 2.57%
271,128 $24.7 Million
Q3 2019

Nov 01, 2019

BUY
$76.08 - $82.93 $7.24 Million - $7.89 Million
95,161 Added 51.96%
278,291 $23.4 Million
Q2 2019

Jul 16, 2019

BUY
$69.84 - $81.59 $1.03 Million - $1.2 Million
14,679 Added 8.71%
183,130 $15.4 Million
Q1 2019

Apr 18, 2019

BUY
$69.58 - $79.36 $955,542 - $1.09 Million
13,733 Added 8.88%
168,451 $14 Million
Q4 2018

Jan 23, 2019

BUY
$65.24 - $75.71 $832,266 - $965,832
12,757 Added 8.99%
154,718 $11.8 Million
Q3 2018

Oct 22, 2018

BUY
$57.69 - $67.84 $1.15 Million - $1.35 Million
19,878 Added 16.28%
141,961 $10.1 Million
Q2 2018

Jul 09, 2018

BUY
$50.83 - $59.72 $1.89 Million - $2.22 Million
37,200 Added 43.83%
122,083 $7.41 Million
Q1 2018

May 11, 2018

BUY
$50.96 - $59.23 $424,445 - $493,326
8,329 Added 10.88%
84,883 $4.62 Million
Q4 2017

Jan 29, 2018

SELL
$51.62 - $61.64 $11,253 - $13,437
-218 Reduced 0.28%
76,554 $4.31 Million
Q3 2017

Nov 16, 2017

BUY
$58.67 - $63.13 $92,346 - $99,366
1,574 Added 2.09%
76,772 $4.92 Million
Q2 2017

Aug 10, 2017

BUY
N/A
19,131 Added 34.12%
75,198 $4.82 Million
Q1 2017

Aug 17, 2017

BUY
N/A
56,067
56,067 $3.56 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Ifm Investors Pty LTD Portfolio

Follow Ifm Investors Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifm Investors Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ifm Investors Pty LTD with notifications on news.